About PRAHA VACCINES
PRAHA VACCINES is a Healthcare company based in Kutna Hora (Czechia) founded in 2017, and was acquired by Novavax in May 2020. Serums and vaccines are developed and produced by PRAHA VACCINES. The company has 4,148 employees. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Vaccines. Its legal entity is ACTIVE 24, s.r.o.
Company details
PRAHA VACCINES was established in 2017 in Kutna Hora, Czech Republic. Operations are centered on the development and production of serums and vaccines within the biotechnology and pharmaceutical sectors. Research activities are conducted to support vaccine manufacturing, with a focus on serum-based solutions. The companys domain, prahavaccines.cz, facilitates information dissemination. Geographic operations remain based in the Czech Republic, serving regional and potential international needs.
- Headquarters Kutna Hora, Czechia
- Employees 4,148
- Stage Acquired
- SectorsHealthcare
- Website prahavaccines.cz
- Acquired by Novavax (May 2020)
- Legal Name Active 24, S.R.O.
Investors in PRAHA VACCINES
PRAHA VACCINES has secured backing from 1 investor. Prominent investors backing the company include Novavax.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Novel vaccines are developed using nanoparticle and matrix adjuvant technology. | 1987 | novavax.com | Gaithersburg, United States |
Investor details for PRAHA VACCINES
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PRAHA VACCINES
2 dated milestones of PRAHA VACCINES across 3 years, from founding to its latest funding, stage changes and deals.
- Founded PRAHA VACCINES is founded.
- Exit Acquired by Novavax.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Praha Vaccines
Complete news archive for PRAHA VACCINES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PRAHA VACCINES
PRAHA VACCINES was founded in 2017.
PRAHA VACCINES is headquartered in Kutna Hora, Czechia. It is registered at Kutna Hora, Central Bohemian Region, Czechia.
PRAHA VACCINES has 4,148 employees.
Annual revenue of PRAHA VACCINES is $8.29M as on Dec 31, 2022.
PRAHA VACCINES was established in 2017 in Kutna Hora, Czech Republic. Operations are centered on the development and production of serums and vaccines within the biotechnology and pharmaceutical sectors. Research activities are conducted to support vaccine manufacturing, with a focus on serum-based solutions. The companys domain, prahavaccines.cz, facilitates information dissemination. Geographic operations remain based in the Czech Republic, serving regional and potential international needs.
PRAHA VACCINES has 1 investor. Key investors include Novavax.
PRAHA VACCINES operates through Active 24, S.R.O..
Yes. PRAHA VACCINES was acquired by Novavax in May 2020.